Valtruis, The Cigna Group Ventures and Tau Ventures led a $28m Series A round in Autonomize AI.

Valtruis, The Cigna Group Ventures and Tau Ventures led a $28m Series A round in Autonomize AI, a pioneer in AI-driven healthcare solutions. “The current healthcare system is no longer suited for the way care is delivered today—and too often, patients and clinicians pay the price in delayed treatment, wasted time, and unnecessary friction. Automation alone is not the answer for healthcare, but accountable, human-centered AI augmentation is. This funding will help us scale our platform to solve some of the most frustrating, high-impact operational challenges in healthcare, while keeping patients and care outcomes at the center,” Ganesh Padmanabhan, Autonomize AI CEO.